Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Sep 23, 2024 · CIK: 1135951
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Dr. Reddy's filed a 6-K, standard procedure for foreign issuers. Nothing major here.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 23, 2024, to report information as a foreign private issuer. The filing confirms their submission of annual reports under Form 20-F and provides their principal executive office address in Hyderabad, India.
Why It Matters
This filing serves as a routine update for investors and regulatory bodies, confirming Dr. Reddy's compliance with reporting requirements as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-001018 (document_id) — Accession Number
- 20240923 (date) — Filing Date
- Hyderabad, India (location) — Principal Executive Office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the issuer makes public in its home country.
Which form does Dr. Reddy's Laboratories Ltd. typically file annual reports under?
Dr. Reddy's Laboratories Ltd. indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address for Dr. Reddy's Laboratories Ltd.?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
When was this Form 6-K filed?
This Form 6-K was filed on September 23, 2024.
Does this filing indicate submission in paper format?
The filing includes check boxes for submitting in paper as permitted by Regulation S-T Rule 101(b)(1) and 101(b)(7), but the primary indication is for filing annual reports under Form 20-F, suggesting a standard electronic submission for the 6-K itself.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-09-23 06:18:20
Filing Documents
- drr0672_6k.htm (6-K) — 14KB
- drr0672_ex99-1.htm (EX-99.1) — 22KB
- drr0672_ex99-1img01.jpg (GRAPHIC) — 7KB
- drr0672_ex99-1img02.jpg (GRAPHIC) — 7KB
- drr0672_ex99-1img03.jpg (GRAPHIC) — 7KB
- 0001575872-24-001018.txt ( ) — 67KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 21, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3